Gene Therapy Market Share, Industry Growth, Business Strategy, Trends and Regional Outlook 2029

Gene Therapy Market size is expected to grow from US$ 7.94 Bn. in 2022 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2023 to 2029. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2029.

Gene Therapy Market Overview:

The “Global Gene Therapy Market Analysis” is an in-depth look at the Gene Therapy market, with a focus on global market trends and analysis. This study seeks to provide an overview of the Gene Therapy industry as well as detailed market segmentation by segment and geography. The Gene Therapy market is expected to expand rapidly over the forecast period. The research contains critical information on the market positions of the top Gene Therapy firms, as well as significant industry trends and opportunities.

Gene Therapy Market Scope:

To validate the market size and estimate the market size by different segments, top-down and bottom-up methodologies are utilized. The research’s market estimates are based on the sale price (excluding any discounts provided by the manufacturer, distributor, wholesaler, or traders). Weights applied to each section based on usage rate and average sale price are used to determine percentage splits, market shares, and segment breakdowns. The percentage adoption or usage of the provided market Size in the relevant area or nation is used to determine the country-wise splits of the overall market and its sub-segments.

Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/global-gene-therapy-market/85074/ 

 

Gene Therapy Market Segmentation:

by Vector Type

Lentivirus
AAV
Retrovirus & gamma Retrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector

by Delivery Method

In Vivo
Ex Vivo

by Gene Type

Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

Acute Lymphoblastic Leukaemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. In 2022, the Spinal Muscular Atrophy (SMA) sector had the biggest market share (41%), and by 2029, it is anticipated that this dominance will persist. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease’s phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA. Zolgensma is the opening speaker in this segment, and

 

Global Gene Therapy Market, by Indication (2022-2029)

• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• ADA-SCID
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others

Global Gene Therapy Market, by Vector Type (2022-2029)

• Lentivirus
• AAV
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector

Global Gene Therapy Market, by Delivery Method (2022-2029)

• In Vivo
• Ex Vivo

Global Gene Therapy Market, by Gene Type (2022-2029)

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide
• Deficiency
• Growth factors
• Receptors
• Others

 

 

 

 

Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/25900 

Gene Therapy Market Key Players:

Primary and secondary research is used to discover industry titans, while primary and secondary research isutilized to assess market revenue. The core research included in-depth interviews with a variety of thought leaders and industry experts, including experienced front-line personnel, CEOs, and marketing specialists. Secondary research comprised an examination of well-known manufacturers’ annual and financial reports. Secondary data is utilized to calculate percentage splits, market shares, growth rates, and global market breakdowns, which are then cross-checked against primary data.The following are a few companies working in the Gene Therapy industry.

1. REGENXBIO, Inc.
2. Bayer
3. Oxford BioMedica plc
4. Dimension Therapeutics, Inc.
5. Bristol-Myers Squibb Company
6. SANOFI
7. Applied Genetic Technologies Corp
8. F. Hoffmann-La Roche Ltd.
9. Bluebird Bio, Inc.
10. Novartis AG
11. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
12. UniQure N.V.
13. Shire Plc;
14. Cellectis S.A.
15. Sangamo Therapeutics, Inc.
16. Orchard Therapeutics
17. Gilead Lifesciences, Inc.
18. Benitec Biopharma Ltd.
19. Sibiono GeneTech Co., Ltd.
20. Shanghai Sunway Biotech Co., Ltd
21. Gensight Biologics S.A.
22. Transgene
23. Calimmune, Inc
24. Epeius Biotechnologies Corp
25. Astellas Pharma, Inc
26. American Gene Technologies
27. BioMarin Pharmaceuticals, Inc.
28. Human Stem Cell Institute
29. Spark Therapeutics LLC
30. GlaxoSmithKline
31. Voyager Therapeutics

Gene Therapy Market Regional Analysis:

The Gene Therapy research focuses into geographic analysis, which is further separated by sub-regions and nations. Profit projections and market share statistics for each country are included in this section of the research. This component of the study examines each region’s and country’s share and growth rate throughout the forecasted time period.

The report provides a thorough PESTEL analysis for all five regions, including North America, Europe, Asia Pacific, the Middle East, Africa, and South America, after considering political, economic, social, and technical issues effecting the Gene Therapy market in various sectors.

Request For Free Sample Report:https://www.maximizemarketresearch.com/request-sample/25900 

COVID-19 Impact Analysis on Gene Therapy Market:

 

Customer behaviour has changed as a result of the COVID-19 virus across all areas of society. Businesses, on the other hand, will need to revise their strategy to account for changing market supply. This report provides an overview of the COVID-19’s influence on the Gene Therapy market and will assist you in developing your business in accordance with the new industry norms.

Under the COVID-19 Impact section, the Gene Therapy Market Report delivers a 360-degree research ranging from the agile supply chain and trade restrictions to regional government policies and the firm’s future impact. Primary market research (2021-2027), instances of venture rivalry, the benefits and drawbacks of large corporate channels, and industry growth trends (2021-2027) have all been provided.

Key Questions Answered in the Gene Therapy Market Report are:

• How big is the market for Gene Therapy?
• Which regional market will emerge as the market leader in the next years?
• Which application category is expected to develop the fastest?
• What opportunities for growth could exist in the Gene Therapy industry in the next years?
• What are the most significant future challenges that the Gene Therapy market may face?
• Who are the market leaders in the Gene Therapy category?
• What are the main trends that are influencing market growth?

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656